⚡⚡(HILO OFICIAL) : CRISIS DEL cobi19 ☣SARS-CoV2☣

[Burbujo II]

Eso de la inmunidad lo dijimos aquí y no precisamente para despreciarlo, de hecho dije que la T-cell mediated immunity iba a salvar al Tegnell (pero ni con esas, LOL).

Tio que no cuela. Nos quieres poner como a unas viejas chochas locas y simplemente exigimos seriedad en la ciencia. Tu sacas aquí cualquier fruta cosa de curva sin contexto y quieres que te alabemos como si fueras el enviado de dios.

Si Science lo pone para mi va a misa. Y si Nature lo pone también. Tu te acabas de descojonar de lo de las horas de luz y la latitud y te acabo de dar con el Nature en todo el gepeto. Porque ni si quiera eres capaz de entrar a analizar por qué puede estar relacionado con la latitud y no con la temperatura. No te alcanza se ve...

Venga, sigue chamaneando que ya nos conocemos. Yo solo exijo Luz y Taquígrafos y responsabilidad en todas las decisiones que se tomen y hasta ahora la ciencia os está perforando un segundo ojete de forma inmisericorde a todos los chamanistas como el @Atanasio Lonchafinista

¿Pero no eráis vosotros los que decíais que eso daba igual, que no era estacional, que mataba en todas partes a la vez, pasara lo que pasara y a todas las edades?

 

[2plx2]

Sin MARIANO no hay NEP.

Pues que se venga también!!!

 

[peñadelaguila]

Mas buenas noticias: las tasas de infección se desploman en la India. Parece ser que puede ser por una resistencia al bichito preexistente por infecciones como cólera, tifus o tuberculosis, por ejemplo.

India's dramatic fall in bichito cases leaves experts stumped



India’s dramatic fall in bichito cases leaves experts stumped
By KRUTIKA PATHI and ANIRUDDHA GHOSALtoday




1 of 14
People wait outside a health center to get tested for el bichito-19 in New Delhi, India, Thursday, Feb. 11, 2021. When the cobi19 pandemic took hold in India, there were antiestéticars it would sink the fragile health system of the world’s second-most populous country. Infections climbed dramatically for months and at one point India looked like it might overtake the United States as the country with the highest case toll. But infections began to plummet in September, and experts aren’t sure why. (AP Photo/Manish Swarup)

NEW DELHI (AP) — When the cobi19 pandemic took hold in India, there were antiestéticars it would sink the fragile health system of the world’s second-most populous country. Infections climbed dramatically for months and at one point India looked like it might overtake the United States as the country with the highest case toll.
But infections began to plummet in September, and now the country is reporting about 11,000 new cases a day, compared to a peak of nearly 100,000, leaving experts perplexed.
ADVERTISEMENT


They have suggested many possible explanations for the sudden drop — seen in almost every region — including that some areas of the country may have reached herd immunity or that Indians may have some preexisting protection from the bichito.
The Indian government has also partly attributed the dip in cases to mask-wearing, which is mandatory in public in India and violations draw hefty fines in some cities. But experts have noted the situation is more complicated since the decline is uniform even though mask compliance is flagging in some areas.
It’s more than just an intriguing puzzle; determining what’s behind the drop in infections could help authorities control the bichito in the country, which has reported nearly 11 million cases and over 155,000 deaths. Some 2.4 million people have died worldwide.


“If we don’t know the reason, you could unknowingly be doing things that could lead to a flare-up,” said Dr. Shahid Jameel, who studies viruses at India’s Ashoka University.
India, like other countries, misses many infections, and there are questions about how it’s counting bichito deaths. But the strain on the country’s hospitals has also declined in recent weeks, a further indication the bichito’s spread is slowing. When recorded cases crossed 9 million in November, official figures showed nearly 90% of all critical care beds with ventilators in New Delhi were full. On Thursday, 16% of these beds were occupied.
That success can’t be attributed to vaccinations since India only began administering shots in January — but as more people get a vaccine, the outlook should look even better, though experts are also concerned about variants identified in many countries that appear to be more contagious and render some treatments and vaccines less effective.

Among the possible explanations for the fall in cases is that some large areas have reached herd immunity — the threshold at which enough people have developed immunity to the bichito, by falling sick or being vaccinated, that the spread begins to slacken, said Vineeta Bal, who studies immune systems at India’s National Institute of Immunology.
But experts have cautioned that even if herd immunity in some places is partially responsible for the decline, the population as a whole remains vulnerable — and must continue to take precautions.
This is especially true because new research suggests that people who got sick with one form of the bichito may be able to get infected again with a new version. Bal, for instance, pointed to a recent survey in Manaus, Brazil, that estimated that over 75% of people there had antibodies for the bichito in October — before cases surged again in January.
“I don’t think anyone has the final answer,” she said.
And, in India, the data is not as dramatic. A nationwide screening for antibodies by Indian health agencies estimated that about 270 million, or one in five Indians, had been infected by the bichito before vaccinations started — that’s far below the rate of 70% or higher that experts say might be the threshold for the cobi19, though even that is not certain.
Related stories
“The message is that a large proportion of the population remains vulnerable,” said Dr. Balram Bhargava, who heads India’s premier medical research body, the Indian Council of Medical Research.
But the survey offered other insight into why India’s infections might be falling. It showed that more people had been infected in India’s cities than in its villages, and that the bichito was moving more slowly through the rural hinterland.
“Rural areas have lesser crowd density, people work in open spaces more and homes are much more ventilated,” said Dr. K. Srinath Reddy, president of the Public Health Foundation of India.
If some urban areas are moving closer to herd immunity — wherever that threshold lies — and are also limiting transmission through masks and physical distancing and thus are seeing falling cases, then maybe the low speed at which the bichito is passing through rural India can help explain sinking numbers, suggested Reddy.
Another possibility is that many Indians are exposed to a variety of diseases throughout their lives — cholera, typhoid and tuberculosis, for instance, are prevalent — and this exposure can prime the body to mount a stronger, initial immune response to a new bichito.
“If the el bichito bichito can be controlled in the nose and throat, before it reaches the lungs, it doesn’t become as serious. Innate immunity works at this level, by trying to reduce the viral infection and stop it from getting to the lungs,” said Jameel, of Ashoka University.

Despite the good news in India, the rise of new variants has added another challenge to efforts here and around the globe to bring the pandemic under control. Scientists have identified several variants in India, including some that have been blamed for causing new infections in people who already had an earlier version of the bichito. But they are still studying the public health implications.
Experts are considering if variants may be driving a surge in cases in the the southern state of Kerala, which had previously been hailed as a blueprint for tackling the bichito. Kerala now accounts for nearly half of India’s current el bichito-19 cases. Government-funded research has suggested that a more contagious version of the bichito could be at play, and efforts to sequence its genome are ongoing.
With the reasons behind India’s success unclear, experts are concerned that people will let down their guard. Large parts of India have already returned to normal life. In many cities, markets are heaving, roads are crowded and restaurants nearly full.
“With the reducing numbers, I feel that the worst of el bichito is over,” said M. B. Ravikumar, an architect who was hospitalized last year and recovered. “And we can all breathe a sigh of relief.”

 

[Scardanelli]

¿Pero no eráis vosotros los que decíais que eso daba igual, que no era estacional, que mataba en todas partes a la vez, pasara lo que pasara y a todas las edades?

Muchos hemos comentado varias veces que era estacional, creo que @lowfour estaba entre ellos. Los que negaban la estacionalidad eran aquellos que con inclinación a querer que las cosas fueran a peor, negaban la estacionalidad en verano, pero la afirmaban cuando entraba el invierno.

El bichito es claramente estacional, es algo que se nota en cómo afecta a determinadas latitudes y zonas geográficas, y lo vamos a volver a ver desde mediados de abril.

 

[dabuti]

¿Que el toque de queda en CYL no vale ya a las 8?

No te lo crees ni tú que el Gobierno nos chulea.

Sujétame el cubata.......cierro los negocios a las 8 y atpc.


La Junta contraataca y limita a las 20.00 horas el horario de hostelería, comercios y establecimientos tras el auto del Supremo

 

[rejon]

La banderilla de Pfizer contra el cobi19, eficaz en un 94%, según un estudio israelí
La principal aseguradora de salud de Israel ha afirmado que la banderilla de Pfizer/BioNTech contra el cobi19 es eficaz en un 94%, según un estudio llevado a cabo con más de un millón de personas vacunadas.

Según la aseguradora Clalit, sus científicos hicieron test con 600.000 personas que recibieron las dos dosis recomendadas de la banderilla y con un número equivalente de personas que no recibieron la inyección.


"Había una reducción del 94% en la tasa de infección sintomática y una bajada del 92% en la tasa de enfermedad grave, comparado con 600.000 [sujetos] similares que no fueron banderilleados", explicó el grupo en un comunicado.

"La eficacia de la banderilla se mantiene en todas las categorías de edad, incluyendo en los mayores de 70 años", agregó.

 

[apolyon]

Salu2

no entiendo nada.. no entiendo nada.. pero nada.. está empeorando jorobar?

 

[apolyon]

La banderilla de Pfizer contra el cobi19, eficaz en un 94%, según un estudio israelí
La principal aseguradora de salud de Israel ha afirmado que la banderilla de Pfizer/BioNTech contra el cobi19 es eficaz en un 94%, según un estudio llevado a cabo con más de un millón de personas vacunadas.

Según la aseguradora Clalit, sus científicos hicieron test con 600.000 personas que recibieron las dos dosis recomendadas de la banderilla y con un número equivalente de personas que no recibieron la inyección.


"Había una reducción del 94% en la tasa de infección sintomática y una bajada del 92% en la tasa de enfermedad grave, comparado con 600.000 [sujetos] similares que no fueron banderilleados", explicó el grupo en un comunicado.

"La eficacia de la banderilla se mantiene en todas las categorías de edad, incluyendo en los mayores de 70 años", agregó.

te paga el laboratorio Pfizer.? bueno ya te contaré de su eficacia en mí.

 

[apolyon]

Mas buenas noticias: las tasas de infección se desploman en la India. Parece ser que puede ser por una resistencia al bichito preexistente por infecciones como cólera, tifus o tuberculosis, por ejemplo.

India's dramatic fall in bichito cases leaves experts stumped



India’s dramatic fall in bichito cases leaves experts stumped
By KRUTIKA PATHI and ANIRUDDHA GHOSALtoday



1 of 14
People wait outside a health center to get tested for el bichito-19 in New Delhi, India, Thursday, Feb. 11, 2021. When the cobi19 pandemic took hold in India, there were antiestéticars it would sink the fragile health system of the world’s second-most populous country. Infections climbed dramatically for months and at one point India looked like it might overtake the United States as the country with the highest case toll. But infections began to plummet in September, and experts aren’t sure why. (AP Photo/Manish Swarup)

NEW DELHI (AP) — When the cobi19 pandemic took hold in India, there were antiestéticars it would sink the fragile health system of the world’s second-most populous country. Infections climbed dramatically for months and at one point India looked like it might overtake the United States as the country with the highest case toll.
But infections began to plummet in September, and now the country is reporting about 11,000 new cases a day, compared to a peak of nearly 100,000, leaving experts perplexed.
ADVERTISEMENT


They have suggested many possible explanations for the sudden drop — seen in almost every region — including that some areas of the country may have reached herd immunity or that Indians may have some preexisting protection from the bichito.
The Indian government has also partly attributed the dip in cases to mask-wearing, which is mandatory in public in India and violations draw hefty fines in some cities. But experts have noted the situation is more complicated since the decline is uniform even though mask compliance is flagging in some areas.
It’s more than just an intriguing puzzle; determining what’s behind the drop in infections could help authorities control the bichito in the country, which has reported nearly 11 million cases and over 155,000 deaths. Some 2.4 million people have died worldwide.


“If we don’t know the reason, you could unknowingly be doing things that could lead to a flare-up,” said Dr. Shahid Jameel, who studies viruses at India’s Ashoka University.
India, like other countries, misses many infections, and there are questions about how it’s counting bichito deaths. But the strain on the country’s hospitals has also declined in recent weeks, a further indication the bichito’s spread is slowing. When recorded cases crossed 9 million in November, official figures showed nearly 90% of all critical care beds with ventilators in New Delhi were full. On Thursday, 16% of these beds were occupied.
That success can’t be attributed to vaccinations since India only began administering shots in January — but as more people get a vaccine, the outlook should look even better, though experts are also concerned about variants identified in many countries that appear to be more contagious and render some treatments and vaccines less effective.

Among the possible explanations for the fall in cases is that some large areas have reached herd immunity — the threshold at which enough people have developed immunity to the bichito, by falling sick or being vaccinated, that the spread begins to slacken, said Vineeta Bal, who studies immune systems at India’s National Institute of Immunology.
But experts have cautioned that even if herd immunity in some places is partially responsible for the decline, the population as a whole remains vulnerable — and must continue to take precautions.
This is especially true because new research suggests that people who got sick with one form of the bichito may be able to get infected again with a new version. Bal, for instance, pointed to a recent survey in Manaus, Brazil, that estimated that over 75% of people there had antibodies for the bichito in October — before cases surged again in January.
“I don’t think anyone has the final answer,” she said.
And, in India, the data is not as dramatic. A nationwide screening for antibodies by Indian health agencies estimated that about 270 million, or one in five Indians, had been infected by the bichito before vaccinations started — that’s far below the rate of 70% or higher that experts say might be the threshold for the cobi19, though even that is not certain.
Related stories
“The message is that a large proportion of the population remains vulnerable,” said Dr. Balram Bhargava, who heads India’s premier medical research body, the Indian Council of Medical Research.
But the survey offered other insight into why India’s infections might be falling. It showed that more people had been infected in India’s cities than in its villages, and that the bichito was moving more slowly through the rural hinterland.
“Rural areas have lesser crowd density, people work in open spaces more and homes are much more ventilated,” said Dr. K. Srinath Reddy, president of the Public Health Foundation of India.
If some urban areas are moving closer to herd immunity — wherever that threshold lies — and are also limiting transmission through masks and physical distancing and thus are seeing falling cases, then maybe the low speed at which the bichito is passing through rural India can help explain sinking numbers, suggested Reddy.
Another possibility is that many Indians are exposed to a variety of diseases throughout their lives — cholera, typhoid and tuberculosis, for instance, are prevalent — and this exposure can prime the body to mount a stronger, initial immune response to a new bichito.
“If the el bichito bichito can be controlled in the nose and throat, before it reaches the lungs, it doesn’t become as serious. Innate immunity works at this level, by trying to reduce the viral infection and stop it from getting to the lungs,” said Jameel, of Ashoka University.

Despite the good news in India, the rise of new variants has added another challenge to efforts here and around the globe to bring the pandemic under control. Scientists have identified several variants in India, including some that have been blamed for causing new infections in people who already had an earlier version of the bichito. But they are still studying the public health implications.
Experts are considering if variants may be driving a surge in cases in the the southern state of Kerala, which had previously been hailed as a blueprint for tackling the bichito. Kerala now accounts for nearly half of India’s current el bichito-19 cases. Government-funded research has suggested that a more contagious version of the bichito could be at play, and efforts to sequence its genome are ongoing.
With the reasons behind India’s success unclear, experts are concerned that people will let down their guard. Large parts of India have already returned to normal life. In many cities, markets are heaving, roads are crowded and restaurants nearly full.
“With the reducing numbers, I feel that the worst of el bichito is over,” said M. B. Ravikumar, an architect who was hospitalized last year and recovered. “And we can all breathe a sigh of relief.”

pero hace un año también había esas resitencias. y hace unos meses.

 

[y esto es todo amigos]

Toda la ciencia subvencionada e institucional de este planeta afirma cosas como que las razas no existen, hombres y mujeres somos iguales y un travelo es igualito de normal que tú. Y al que disienta, se le quita hasta el premio Nobel si hace falta como se hizo con James Watson

Resulta que la 100cia sí puede ponerse de acuerdo -el consenso, lo más anticientífico que existe- para imponer verdades de categoría dogmática instantaneamente

Esto no quiere decir que el bichito no exista o si exista, solo que lo que la existencia de lo que tu llamas conspiracion es una realidad muy posible y de hecho cada vez es más la norma

Si y no, ese es otro debate. Es lo que yo llamo ciencia "dirigida", o el que paga manda. Pero eso ha pasado siempre y no invalida a la ciencia en general, invalida a científicos que algunos hasta se han inventado ensayos, por eso se insiste tanto en la revisión de los ensayos y en que se puedan repetir y validar por otros científicos.

 

[Burbujo II]

La OMS calcula que, a nivel MUNDIAL, se detectan uno de cada 22 casos.

Lo que daría un 0,13% letalidad IFR.

Los test de antígenos no detectan a todos los que lo han pasado. Tampoco detectan las células B/T.

Y aquí tienes al epidemiólogo referencia mundial de Harvard, que es además uno de los médicos científicos más citados del mundo:

The infection fatality rate of el bichito-19 inferred from seroprevalence data

Le da entre un 0,27% y un 0,24% de letalidad.

Los chamanes somos así, todo el día habando de magufos.

 

[zapatitos]

¿tanto rollo para decir que eres un negacionista terraplanista sologripista? En tú lenguaje ¿un negaidiota?.

Que pena zapatitos, has caído en las garras de la secta terraplanista sologripista, ¿Cómo te has dejado engañar por algo tan burdo?

¿realmente piensas que toda la ciencia mundial se ha conjurado para decir que la gripe es el el bichito? Supongo yo que los enfermos que entran en los hospitales son actores, que las van "matando" y rotando por los hospitales.

¿Cómo en tu secta podéis decir tantas insensateces y llamar idiotas a los demás?

Y sigues con tu burda manipulación goebbeliana poniendo palabras en mi boca que jamás he pronunciado.

¿Donde he puesto yo que la ciencia se haya conjurado para decir que la gripe es el bichito?

¿Donde he puesto yo que los enfermos que entran en los hospitales son imaginarios o unos actores?

Lee un poco (si es que sabes hacerlo claro está) sobre Psicología.



- Pavlov

- La Cueva de los Ladrones

- El Efecto Espectador

- El Experimento del Pequeño Albert

- Los Experimentos de Harlow

- Indefensión Aprendida

- Milgram

- Efecto Golem

- Asch

Todo eso y más lo utilizan a diario contra ti porque entre otras cosas saben que eres estulto y te lo tragas todo.

Y el problema no es ser estulto que todos más o menos alguna vez lo hemos sido y lo hemos hecho en nuestras vidas que nadie es mejor que nadie y yo tampoco soy mejor que nadie, el problema es que incluso estés orgulloso de ser lo que eres osease un completo borrego subnormalizado por múltiples estímulos programados desde múltiples canales para que lo seas.

Saludos.

 

[apolyon]

Claro, claro.. y a mí el champú nunca se me acaba,,, voy rellenando con agua y así in aeternum

El logro de Ana y Natalia, dos enfermeras españolas que logran sacar una séptima dosis del 'botecito' de la banderilla Pfizer

El logro de Ana y Natalia, dos enfermeras españolas que logran sacar una séptima dosis del 'botecito' de la banderilla Pfizer

 

[rejon]

Venezuela envía otros dos camiones de oxígeno a Brasil para atender el bichito-19


No decian que Maduro era, mala persona???

No que vá....es un hijo de la gran fruta...asesino...

 

[Ramonmo]

Son magufos, según necesidad dirán una cosa y su contraria, a la vez, sin despeinarse ni cambiar el rictus.

Primero las restricciones, luego las mascaras, luego las banderillas (a mí me sigue dando mucho respeto que las hayan terminado de desarrollar en meses, aunque el uso de ARNm lleva en estudio años).
Luego seguirán con las cepas, cuando haya una que realmente sea capaz de eludir al sistema inmunológico, bien por haber pasado la infección, bien por estar medicado.

Pero el maguferío siempre estará igual.

Porque no saben leer una fruta gráfica, en primer lugar, ya que no conocen el contexto de dicha gráfica... mejor dicho, buscan ocultar dicho contexto para manipular y mentir.

30 "papers" que dicen que las medidas no farmacológicas no sirven | Burbuja.info: Foro de economía, política y actualidad.

Toma, HI JO DE PU TA.

Para que practiques con el Google translator, A NAL FA BE TO.